71 results on '"Engert, Andreas"'
Search Results
2. ESG Ratings—Guiding a Movement in Search for Itself
3. Equality Between Efficiency and Distribution—A Law-and-Economics Reconceptualization of a Principle of Justice
4. Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial
5. In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection
6. HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
7. Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer
8. Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
9. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
10. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
11. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
12. Gleichheit zwischen Effizienz und Verteilung – rechtsökonomische Rekonstruktion eines Gerechtigkeitspostulats (Equality Between Efficiency and Distribution – A Law-and-Economics Re-Conceptualization of a Principle of Justice)
13. Shareholder Activism in Germany
14. Which Related Party Transactions Should Be Subject to Ex Ante Review? Evidence from Germany
15. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials
16. Market standards in financial contracting: The Euro’s effect on debt securities
17. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
18. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
19. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
20. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
21. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
22. Costs of haematological disease high and rising
23. Hodgkin lymphoma: Introduction
24. Treatment of early-stage Hodgkin lymphoma
25. PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma—a systematic review and meta-analysis
26. Relapse Analysis of Irradiated Patients Within the HD15 Trial of the German Hodgkin Study Group
27. Hodgkin's lymphoma: who needs consolidation treatment?
28. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
29. Where do firms issue debt? An empirical analysis of issuer location and regulatory competition in Europe
30. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis
31. Why Manager Liability Fails at Controlling Systemic Risk
32. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
33. Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
34. Why Agents Need Discretion: The Business Judgment Rule as Optimal Standard of Care
35. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
36. Contracting Over Private Benefits of Control
37. Does Charter Competition Foster Entrepreneurship? A Difference-in-Difference Approach to European Company Law Reforms
38. Can Network Effects Impede Optimal Contracting in Debt Securities?
39. Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
40. Does Charter Competition Foster Entrepreneurship? A Difference-in-Difference Approach to European Company Law Reforms
41. Proceedings of the 13th biennial South African Lymphoma Study Group Meeting – Cape Town October 2008
42. Where Do Firms Issue Debt? An Empirical Analysis of Issuer Location and Regulatory Competition in Europe
43. Migration and interleukin-8 release of granulocytes by soluble and nanovesicle-associated CD30 from hodgkin lymphoma cells
44. Epoetins and mortality in patients with cancer – Authors' reply
45. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
46. Biomarkers and Prognosis in Malignant Lymphomas
47. Radiotherapy Does Not Influence the Severe Pulmonary Toxicity Observed With the Administration of Gemcitabine and Bleomycin in Patients With Advanced-Stage Hodgkin's Lymphoma Treated With the BAGCOPP Regimen: A Report by the German Hodgkin's Lymphoma Study Group
48. Incorporating under European Law: The Societas Europaea as a Vehicle for Legal Arbitrage
49. Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells
50. A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma—Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.